GKOSGlaukos Corporation
Slide 1 of 3
Company Overview
Name
Glaukos Corporation
52W High
$163.71
52W Low
$73.16
Market Cap
$5.5B
Dividend Yield
0%
Price/earnings
-0.28
P/E
-0.28
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$133.5M
Operating Revenue
$133.5M
Total Gross Profit
$104.7M
Total Operating Income
$-16.4M
Net Income
$-16.2M
EV to EBITDA
$0.00
EV to Revenue
$11.21
Price to Book value
$7.20
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$83M
Research & Development Expense
$38.1M
Total Operating Expenses
$-121.1M
Interest Expense
$-1.2M
Interest & Investment Income
$2.6M
Other Income / (Expense), net
$-1M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Glaukos Corporation
52W High
$163.71
52W Low
$73.16
Market Cap
$5.5B
Dividend Yield
0%
Price/earnings
-0.28
P/E
-0.28
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$133.5M
Operating Revenue
$133.5M
Total Gross Profit
$104.7M
Total Operating Income
$-16.4M
Net Income
$-16.2M
EV to EBITDA
$0.00
EV to Revenue
$11.21
Price to Book value
$7.20
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$83M
Research & Development Expense
$38.1M
Total Operating Expenses
$-121.1M
Interest Expense
$-1.2M
Interest & Investment Income
$2.6M
Other Income / (Expense), net
$-1M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Thomas W. Burns
Location
California, USA
Exchange
NYSE
Website
https://glaukos.com
Summary
Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Company Info
CEO
Thomas W. Burns
Location
California, USA
Exchange
NYSE
Website
https://glaukos.com
Summary
Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
